Disposables in the Quality Control Laboratory - - BioPharm International


Disposables in the Quality Control Laboratory

BioPharm International

Other measuring equipment is routinely tested for accuracy and reproducibility before being used, but disposable pipettes are rarely checked. In one case, a laboratory was checking its spectrophotometer by measuring the absorbance and the wavelength of maximum absorbance of a carefully prepared solution of an inorganic salt. The linearity of the instrument at the maximum wavelength was checked by making a series of dilutions using a disposable 5 mL pipette and several disposable 1 mL serological pipettes. A plot of the results showed that the spectrophotometer was more or less linear, but the points did not fall along a straight line. Statistical calculations showed that, while linear, the readings were highly variable. The samples were read on a second spectrophotometer that confirmed the erratic readings. The serological pipettes that were used to prepare the dilutions were rinsed and used to pipette known volumes of water which were weighed. The results showed that far from pipetting a reproducible volume of 0.10 mL, the pipettes were delivering volumes ranging from 0.085 mL to 0.17 mL.

Another area of concern has to do with the composition of the disposables. Are they really made from the materials that are stated on the labels? Does the laboratory really know what materials are acceptable for its work? When glass vials are used as containers for products, especially parenterals, there are QC tests that must be done to verify the type of glass being used. For example, the United States Pharmacopeia contains tests for the acceptability of borosilicate and flint glass. There are situations where the properties of the types of glass are very important; what about disposable beakers and sample bottles?

Analysts and biochemists who deal with blood coagulation factors and membrane-bound proteins and enzymes are familiar with problems caused by surfaces that activate or adsorb material and produce changes in the apparent potency of preparations. Certain types of proteins are known to bind to polymers such as agarose, cellulose, and polyamides. Thus the composition of microtiter plates, pipettes, and test tubes could affect the outcome of tests.

An assay is often validated using disposables with a given composition. If the composition changes, there may be subtle, but real changes in the properties of the assay. Changes of this type are usually assumed not to affect an assay, and careful checking is not done.

Some people will now wave their hands about and insist that these cautionary tales are exaggerations of highly infrequent events. These people are certainly entitled to their opinions, but they are exactly that—opinions.

Years ago there was a commercial for a national, fast-food, hamburger chain in which an elderly woman asked repeatedly and querulously, "Where's the beef?"

In a GMP environment, the question becomes, "Where's the proof?"

Steven Kuwahara, PhD, is the principal consultant at GXP BioTechnology LLC, PMB 506, 1669-2 Hollenbeck Ave., Sunnyvale, CA 94087; Tel 408.530.9338,

blog comments powered by Disqus



Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here